Search Results - "Allocati, Eleonora"

Switching Among Biosimilars: A Review of Clinical Evidence by Allocati, Eleonora, Godman, Brian, Gobbi, Marco, Garattini, Silvio, Banzi, Rita

“…Biological medicines have improved patients' outcomes, but their high costs may limit access. Biosimilars, alternatives that have demonstrated high similarity…”
Get full text

Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera by Beeg, Marten, Burti, Cesare, Allocati, Eleonora, Ciafardini, Clorinda, Banzi, Rita, Nobili, Alessandro, Caprioli, Flavio, Garattini, Silvio, Gobbi, Marco

“…Measurements of serum concentrations of therapeutic antibodies and anti-drug antibodies (ADA) can support clinical decisions for the management of…”
Get full text

Clinical evidence supporting the marketing authorization of biosimilars in Europe by Allocati, Eleonora, Bertele’, Vittorio, Gerardi, Chiara, Garattini, Silvio, Banzi, Rita

“…Purpose To review the marketing authorization of biosimilars and provide a critical analysis of the pivotal trials supporting their approval by the European…”
Get full text

A Surface Plasmon Resonance-Based Assay for Simultaneous Measurement of Serum Concentrations of Therapeutic Antibodies and Anti-Drug Antibodies by Beeg, Marten, Allocati, Eleonora, Gobbi, Marco

“…The monitoring of the blood levels of therapeutic antibodies and their immune responses is proposed to guide and optimize therapy with these expensive drugs…”
Get more information

Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications by Tubic, Biljana, Marković-Peković, Vanda, Jungić, Saša, Allocati, Eleonora, Godman, Brian

“…Background: Monoclonal antibodies (mAbs) represent the most numerous and significant group of biotherapeutics. While mAbs have undoubtedly improved treatment…”
Get full text

Optimizing the Clinical Efficacy and Safety of Biological Medicines and Their Biosimilars Within Available Resources in Europe by Allocati, Eleonora

“…Introduction:Biological medicines contain active principles made by large and complex molecular structures, produced or extracted from a biological source…”
Get full text

Long-Term Follow-Up of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: Aims and Methodological Approach for Fondazione Italiana Linfomi Systematic Reviews by Gerardi, Chiara, Allocati, Eleonora, Minoia, Carla, Guarini, Attilio, Banzi, Rita

“…Advances in diagnosis and treatment of hematological malignancies has boosted attention on optimal follow-up care of survivors after cancer. To collect…”
Get full text

Use of High Energy Devices (HEDs) versus electrocautery for laparoscopic cholecystectomy: a systematic review and meta-analysis of randomised controlled trials by Ortenzi, Monica, Agresta, Ferdinando, Vettoretto, Nereo, Gerardi, Chiara, Allocati, Eleonora, Botteri, Emanuele, Montori, Giulia, Balla, Andrea, Arezzo, Alberto, Piatto, Giacomo, Sartori, Alberto, Antoniou, Stavros, Podda, Mauro

“…Introduction According to the literature, there is no clear definition of a High Energy Devices (HEDs), and their proper indications for use are also unclear…”
Get full text

Systematic review and meta-analysis of the use of high-energy devices for thyroid surgery by Montori, Giulia, Botteri, Emanuele, Ortenzi, Monica, Gerardi, Chiara, Allocati, Eleonora, Giordano, Alessio, Vettoretto, Nereo, Arezzo, Alberto, Huo, Bright, Bergamini, Carlo, Podda, Mauro, Agresta, Ferdinando

“…background We conducted a systematic review and meta-analysis to evaluate the role of High Energy Devices (HEDs) versus conventional clamp and tie technique in…”
Get full text

Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi by Franceschetti, Silvia, Annunziata, Maria Antonietta, Agostinelli, Giulia, Gerardi, Chiara, Allocati, Eleonora, Minoia, Carla, Guarini, Attilio

“…Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years…”
Get full text

Male and Female Fertility: Prevention and Monitoring Hodgkin’ Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors. A Systematic Review by the Fondazione Italiana Linfomi by Viviani, Simonetta, Caccavari, Valentina, Gerardi, Chiara, Ramadan, Safaa, Allocati, Eleonora, Minoia, Carla, Guarini, Attilio, Di Russo, Anna

“…Background: Adult patients with Hodgkin lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL) have prolonged survival but face the risk of treatment-induced…”
Get full text

The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi by Minoia, Carla, Gerardi, Chiara, Allocati, Eleonora, Daniele, Antonella, De Sanctis, Vitaliana, Bari, Alessia, Guarini, Attilio

“…Background: In recent years, the scientific community has been paying ever more attention to the promotion of lifestyles aimed at the prevention of late…”
Get full text

Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi by Di Molfetta, Sergio, Daniele, Antonella, Gerardi, Chiara, Allocati, Eleonora, Minoia, Carla, Loseto, Giacomo, Giorgino, Francesco, Guarini, Attilio, De Sanctis, Vitaliana

“…Overall survival after lymphoma has improved in recent years, but the high prevalence of late treatment-related sequelae has been observed as a counterpart. In…”
Get full text

High-energy devices in different surgical settings: lessons learnt from a full health technology assessment report developed by SICE (Società Italiana di Chirurgia Endoscopica) by Vettoretto, Nereo, Foglia, Emanuela, Gerardi, Chiara, Lettieri, Emanuele, Nocco, Umberto, Botteri, Emanuele, Bracale, Umberto, Caracino, Valerio, Carrano, Francesco Maria, Cassinotti, Elisa, Giovenzana, Marco, Giuliani, Beatrice, Iossa, Angelo, Milone, Marco, Montori, Giulia, Peltrini, Roberto, Piatto, Giacomo, Podda, Mauro, Sartori, Alberto, Allocati, Eleonora, Ferrario, Lucrezia, Asperti, Federica, Songia, Letizia, Garattini, Silvio, Agresta, Ferdinando

“…Background The present paper aims at evaluating the potential benefits of high-energy devices (HEDs) in the Italian surgical practice, defining the comparative…”
Get full text

Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi by Oliva, Stefano, Puzzovivo, Agata, Gerardi, Chiara, Allocati, Eleonora, De Sanctis, Vitaliana, Minoia, Carla, Skrypets, Tetiana, Guarini, Attilio, Gini, Guido

“…Cardiotoxicity represents the most frequent cause with higher morbidity and mortality among long-term sequelae affecting classical Hodgkin lymphoma (cHL) and…”
Get full text

Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Bari, Alessia, Gerardi, Chiara, Allocati, Eleonora, Puzzovivo, Agata, De Sanctis, Vitaliana, Tucci, Alessandra, Balzarotti, Monica, Franceschetti, Silvia, Merli, Francesco, Guarini, Attilio, Gini, Guido, Minoia, Carla

“…Compared to other patients suffering from hematological malignancies, classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) patients have…”
Get full text

Cystic fibrosis carrier screening: a Health technology assessment. by Colombo, Cinzia, Banzi, Rita, Gerardi, Chiara, Allocati, Eleonora, Mosconi, Paola, Foglia, Emanuela, Ferrario, Lucrezia, Romano, Francesca, Castellani, Carlo

“…This project of Health technology assessment was aimed at defining the impacts of offering a cystic fibrosis (CF) carrier screening to the general population,…”
Get more information

Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi by Nassi, Luca, De Sanctis, Vitaliana, Loseto, Giacomo, Gerardi, Chiara, Allocati, Eleonora, Ciavarella, Sabino, Minoia, Carla, Guarini, Attilio, Bari, Alessia

“…The increase of lymphoma patient survival led to a modification of the incidence of long-term sequelae, including second malignancies (SM). Several groups have…”
Get full text

Evidence-based public policy making for medicines across countries: findings and implications for the future by Godman, Brian, Fadare, Joseph, Kwon, Hye-Young, Dias, Carolina Zampirolli, Kurdi, Amanj, Dias Godói, Isabella Piassi, Kibuule, Dan, Hoxha, Iris, Opanga, Sylvia, Saleem, Zikria, Bochenek, Tomasz, Marković-Peković, Vanda, Mardare, Ileana, Kalungia, Aubrey C, Campbell, Stephen, Allocati, Eleonora, Pisana, Alice, Martin, Antony P, Meyer, Johanna C

“…Global expenditure on medicines is rising up to 6% per year driven by increasing prevalence of non-communicable diseases (NCDs) and new premium priced…”
Get full text

Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications” by Godman, Brian, Wladysiuk, Magdalene, McTaggart, Stuart, Kurdi, Amanj, Allocati, Eleonora, Jakovljevic, Mihajlo, Kalemeera, Francis, Hoxha, Iris, Nachtnebel, Anna, Sauermann, Robert, Hinteregger, Manfred, Marković-Peković, Vanda, Tubic, Biljana, Petrova, Guenka, Tachkov, Konstantin, Slabý, Juraj, Nejezchlebova, Radka, Krulichová, Iva Selke, Laius, Ott, Selke, Gisbert, Langner, Irene, Harsanyi, András, Inotai, András, Jakupi, Arianit, Henkuzens, Svens, Garuolienė, Kristina, Gulbinovič, Jolanta, Bonanno, Patricia Vella, Rutkowski, Jakub, Ingeberg, Skule, Melien, Øyvind, Mardare, Ileana, Fürst, Jurij, MacBride-Stewart, Sean, Holmes, Carol, Pontes, Caridad, Zara, Corinne, Pedrola, Marta Turu, Hoffmann, Mikael, Kourafalos, Vasileios, Pisana, Alice, Banzi, Rita, Campbell, Stephen, Wettermark, Bjorn

“…[This corrects the article DOI: 10.1155/2021/9996193.]…”
Get full text